Xin Liu focuses on transition‑metal catalysis for arene functionalization and modular heterocycle assembly, alongside chemical biology of cancer—epigenetic regulation, tumor microenvironment, and therapy resistance—using multi‑omics to identify biomarkers and guide translational therapeutics.